ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,620Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 95

$877K Total Retail Price of All Prescriptions

Rank: 7 out of 95

501 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 501 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 501 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 11,342 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 704 562 1 1
LISINOPRIL 605 466 2 3
LEVOTHYROXINE SODIUM 493 424 3 2
PANTOPRAZOLE SODIUM 433 365 4 23
METFORMIN HCL 422 338 5 9
FUROSEMIDE 392 312 6 5
ATORVASTATIN CALCIUM 364 337 7 11
SYNTHROID 320 279 8 36
HYDROCHLOROTHIAZIDE 302 236 9 14
OMEPRAZOLE 272 190 10 4
AMLODIPINE BESYLATE 270 257 11 6
GABAPENTIN 267 192 12 20
METOPROLOL TARTRATE 198 154 13 7
HYDROCODONE-ACETAMINOPHEN 193 145 S3 14 10
ATENOLOL 186 159 15 12
CELEBREX 178 140 16 48
POTASSIUM CHLORIDE 176 136 17 15
SERTRALINE HCL 174 74 18 18
DIOVAN 173 164 19 25
JANUVIA 165 161 20 70
WARFARIN SODIUM 140 122 21 8
NEXIUM 136 81 22 29
CITALOPRAM HBR 134 78 23 16
TRAMADOL HCL 134 96 23 17
ALENDRONATE SODIUM 132 116 25 37
CLOPIDOGREL 123 96 26 21
GLIPIZIDE XL 119 112 27 93
ALLOPURINOL 119 110 27 30
ZOLPIDEM TARTRATE 116 83 29 22
ESCITALOPRAM OXALATE 110 94 30 45
ZETIA 107 81 31 58
PRAVASTATIN SODIUM 105 100 32 26
PLAVIX 105 87 32 34
CYMBALTA 105 60 32 85
TAMSULOSIN HCL 101 97 35 27
METOPROLOL SUCCINATE 100 95 36 13
PAROXETINE HCL 100 68 36 57
DONEPEZIL HCL 97 85 38 19
CARVEDILOL 94 76 39 33
KLOR-CON M20 90 73 40 40
NAMENDA 88 85 41 39
NAPROXEN 85 49 42 103
FLUTICASONE PROPIONATE 85 77 42 62
FENOFIBRATE 84 60 44 109
DETROL LA 83 59 45 133
DIGOXIN 80 67 46 32
AZITHROMYCIN 75 57 47 24
CRESTOR 73 51 48 28
ADVAIR DISKUS 72 68 49 53
PREDNISONE 70 43 50 44
MELOXICAM 70 45 50 84
BISOPROLOL FUMARATE 69 68 52 168
CYCLOBENZAPRINE HCL 62 27 R 53 116
DILTIAZEM 24HR ER 59 58 54 105
TRICOR 59 51 54 118
CIPROFLOXACIN HCL 55 48 56 52
SPIRONOLACTONE 54 40 57 88
LIPITOR 54 45 57 87
GLIPIZIDE 53 41 59 63
GLIPIZIDE ER 52 40 60 120
ACTOS 52 32 60 120
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 3, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.